Association of the CC chemokine receptor 5 (CCR5) polymorphisms with preeclampsia in Turkish women

Archives of Gynecology and Obstetrics

Volumn 286, Issue 1, 2012, Pages 51-54

  Gurdol, Figen ^a   Yurdum, Leman M ^b   Ozturk, Ummühan ^a   Isbilen, Elif ^a   Cakmakoglu, Bedia ^b  

^a ISTANBUL UNIVERSITY   (Turkey)

^b ISTANBUL UNIVERSITY   (Turkey)

Author keywords

Chemokines; Polymorphism; Preeclampsia; Receptor

Indexed keywords

CHEMOKINE RECEPTOR CCR5; GENOMIC DNA;

ADULT; ALLELE; ARTICLE; CHEMOKINE RECEPTOR CCR5 GENE; CHI SQUARE TEST; CONTROLLED STUDY; ETHNIC GROUP; FEMALE; FISHER EXACT TEST; GENE; GENE DELETION; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; POINT MUTATION; POLYMERASE CHAIN REACTION; PREECLAMPSIA; PROMOTER REGION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; TURKISH; WILD TYPE;

ALLELES; CONFIDENCE INTERVALS; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENOTYPE; HUMANS; ODDS RATIO; POLYMORPHISM, GENETIC; PRE-ECLAMPSIA; PREGNANCY; RECEPTORS, CCR5; TURKEY;

EID: 84864495031     PISSN: 09320067     EISSN: 14320711     Source Type: Journal    
DOI: 10.1007/s00404-012-2244-3     Document Type: Article

References (25)

1. Wolf M, Kettyle E, Sandler L, Ecker JL, Roberts J, Thadhani R (2001) Obesity and preeclampsia: the potential role of inflammation. Obstet Gynecol 98:757-762
2. Keelan JA, Mitchell MD (2007) Placental cytokines and pre-eclampsia. Front Biosci 12:2706-2727
3. Poston L (2006) Endothelial dysfunction in pre-eclampsia. Pharmacol Rep 58(Suppl):69-74
4. Conrad KP, Miles TM, Benyo DF (1998) Circulating levels of immunoreactive cytokines in women with preeclampsia. Am J Reprod Immunol 40:102-111
5. Lockwood CJ, Matta P, Krikun G, Koopman LA, Masch R, Toti P et al (2006) Regulation of monocyte chemoattractant protein-1 expression by tumor necrosis factor-alpha and interleukin-1beta in first trimester human decidual cells: implications for pre-eclampsia. Am J Pathol 168:445-452
6. Samson M, Soularue P, Vassart G, Parmentier M (1996) The genes encoding the human CC-chemokine receptors CC-CKR1 to CC-CKR5 (CMKBR1-CMKBR5) are clustered in the p21.3-p24 region of chromosome 3. Genomics 36:522-526
7. Lucotte G (2001) Distribution of the CCR5 gene 32-basepair deletion in West Europe. A hypothesis about the possible dispersion of the mutation by the Vikings in historical times. Hum Immunol 62:933-936
8. Venkatesan S, Petrovic A, Van Ryk DI, Locati M, Weissman D, Murphy PM (2002) Reduced cell surface expression of CCR5 in CCR5 delta 32 heterozygotes is mediated by gene dosage, rather than by receptor sequestration. J Biol Chem 277:2287-2301
9. Zapico I, Coto E, Rodŕiguez A, Alvarez C, Torre JC, Alvarez V (2000) CCR5 (chemokine receptor-5) DNA-polymorphism influences the severity of rheumatoid arthritis. Genes Immun 1:288-289
10. Samson M, Libert F, Doranz BJ, Rucker J, Liesnard C, Farber CM et al (1996) Resistance to HIV-1 infection in Caucasian individuals bearing mutant alleles of the CCR-5 chemokine receptor gene. Nature 382:722-725
11. Rossol M, Pierer M, Arnold S, Keysser G, Burkhardt H, Baer-wald C, Wagner U (2009) Negative association of the chemokine receptor CCR5 D32 polymorphism with systemic inflammatory response, extra-articular symptoms and joint erosion in rheumatoid arthritis. Arthritis Res Ther 11:R9
12. Lockwood CJ, Yen CF, Basar M, Kayisli UA, Martel M, Bu-himschi I et al (2008) Preeclampsia-related inflammatory cyto-kines regulate interleukin-6 expression in human decidual cells. Am J Pathol 172:1571-1579
13. Shieh B, Liau YE, Hsieh PS, Yan YP, Wang ST, Li C (2000) Influence of nucleotide polymorphisms in the CCR2 gene and the CCR5 promoter on the expression of cell surface CCR5 and CXCR4. Int Immunol 12:1311-1318
14. Miller SA, Dykes DD, Polesky HS (1988) Simple salting-out procedure for extracting DNA from human nucleated cells. Nucl Acid Res 16:1215
15. Eskenazi B, Fenster L, Sidney S (1991) A multivariate analysis of risk factors for preeclampsia. JAMA 266:237-241
16. MacKay AP, Berg CJ, Atrash HK (2001) Pregnancy-related mortality from preeclampsia and eclampsia. Obstet Gynecol 97:533-588
17. Zhang J, Meikle S, Trumble A (2003) Severe maternal morbidity associated with hypertensive disorders in pregnancy in the United States. Hypertens Pregnancy 22:203-212
18. Stephens JC, Reich DE, Goldstein DB, Shin HD, Smith MW, Carrington M et al (1998) Dating the origin of the CCR5-Delta32 AIDS-resistance allele by the coalescence of haplotypes. Am J Hum Genet 62:1507-1515
19. Wang CR, Guo HR, Liu MF (2005) RANTES promoter polymorphism as a genetic risk factor for rheumatoid arthritis in the Chinese. Clin Exp Rheumatol 23:379-384
20. Hummel S, Schmidt D, Kremeyer B, Herrmann B, Oppermann M (2005) Detection of the CCR5-32 HIV resistance gene in Bronze Age skeletons. Genes Immun 6:371-374
21. Karaali ZE, Sozen S, Yurdum M, Cacina C, Toptas B, Gok O, Agachan B (2010) Effect of genetic variants of chemokine receptors on the development of myocardial infarction in Turkish population. Mol Biol Rep 37:3615-3619
22. Zenclussen AC, Fest S, Joachim RA, Hagen E, Klapp BF, Arck PC (2002) Increased expression of chemokine receptor 5 (CCR5) in blood and decidual cells in a mouse model for preeclampsia (PE). Am J Reprod Immunol 48:151-151(1)
23. McDermott DH, Zimmerman PA, Guignard F, Kleeberger CA, Leitman SF, Murphy PM (1998) CCR5 promoter polymorphism and HIV-1 disease progression. Multicenter AIDS Cohort Study (MACS). Lancet 352:866-870
24. Abdi R, Huong TTB, Sahagun-Ruiz A, Murphy PM, Brenner BM, Milford EL, McDermott DH (2002) Chemokine receptor polymorphism and risk of acute rejection in human renal transplantation. J Am Soc Nephrol 13:754-758
25. Mellembakken JR, Aukrust P, Hestdal K, Ueland T, Abyholm T, Videm V (2001) Chemokines and leukocyte activation in the fetal circulation during preeclampsia. Hypertension 38:394-398